310 related articles for article (PubMed ID: 12023581)
1. TTF-1 expression in pulmonary adenocarcinomas.
Yatabe Y; Mitsudomi T; Takahashi T
Am J Surg Pathol; 2002 Jun; 26(6):767-73. PubMed ID: 12023581
[TBL] [Abstract][Full Text] [Related]
2. TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma.
Bakir K; Koçer NE; Deniz H; Güldür ME
Ann Diagn Pathol; 2004 Dec; 8(6):337-41. PubMed ID: 15614737
[TBL] [Abstract][Full Text] [Related]
3. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas.
Moldvay J; Jackel M; Bogos K; Soltész I; Agócs L; Kovács G; Schaff Z
Pathol Oncol Res; 2004; 10(2):85-8. PubMed ID: 15188024
[TBL] [Abstract][Full Text] [Related]
4. Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.
Tanaka H; Yanagisawa K; Shinjo K; Taguchi A; Maeno K; Tomida S; Shimada Y; Osada H; Kosaka T; Matsubara H; Mitsudomi T; Sekido Y; Tanimoto M; Yatabe Y; Takahashi T
Cancer Res; 2007 Jul; 67(13):6007-11. PubMed ID: 17616654
[TBL] [Abstract][Full Text] [Related]
5. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
Zamecnik J; Kodet R
Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.
Abutaily AS; Addis BJ; Roche WR
J Clin Pathol; 2002 Sep; 55(9):662-8. PubMed ID: 12194995
[TBL] [Abstract][Full Text] [Related]
7. TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.
Aulakh KS; Chisholm CD; Smith DA; Speights VO
Arch Pathol Lab Med; 2013 Aug; 137(8):1094-8. PubMed ID: 23899066
[TBL] [Abstract][Full Text] [Related]
8. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
[TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.
Myong NH
J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324
[TBL] [Abstract][Full Text] [Related]
11. Thyroid transcription factor 1 in pulmonary adenocarcinoma.
Stenhouse G; Fyfe N; King G; Chapman A; Kerr KM
J Clin Pathol; 2004 Apr; 57(4):383-7. PubMed ID: 15047742
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
Schilsky JB; Ni A; Ahn L; Datta S; Travis WD; Kris MG; Chaft JE; Rekhtman N; Hellmann MD
Lung Cancer; 2017 Jun; 108():205-211. PubMed ID: 28625636
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.
Pelosi G; Fraggetta F; Pasini F; Maisonneuve P; Sonzogni A; Iannucci A; Terzi A; Bresaola E; Valduga F; Lupo C; Viale G
Am J Surg Pathol; 2001 Mar; 25(3):363-72. PubMed ID: 11224607
[TBL] [Abstract][Full Text] [Related]
14. The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma.
Kunii R; Jiang S; Hasegawa G; Yamamoto T; Umezu H; Watanabe T; Tsuchida M; Hashimoto T; Hamakubo T; Kodama T; Sasai K; Naito M
Histopathology; 2011 Feb; 58(3):467-76. PubMed ID: 21348892
[TBL] [Abstract][Full Text] [Related]
15. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis.
Chan AC; Chan JK
Am J Surg Pathol; 2000 Nov; 24(11):1531-6. PubMed ID: 11075855
[TBL] [Abstract][Full Text] [Related]
17. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade.
Jerome Marson V; Mazieres J; Groussard O; Garcia O; Berjaud J; Dahan M; Carles P; Daste G
Histopathology; 2004 Aug; 45(2):125-34. PubMed ID: 15279630
[TBL] [Abstract][Full Text] [Related]
18. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S
Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215
[TBL] [Abstract][Full Text] [Related]
19. Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Acta Cytol; 2010; 54(3):277-82. PubMed ID: 20518411
[TBL] [Abstract][Full Text] [Related]
20. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung.
Di Loreto C; Puglisi F; Di Lauro V; Damante G; Beltrami CA
Cancer Lett; 1998 Feb; 124(1):73-8. PubMed ID: 9500194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
